Last reviewed · How we verify
INDOMETHACIN SODIUM
At a glance
| Generic name | INDOMETHACIN SODIUM |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1985 |
Approved indications
Common side effects
Key clinical trials
- Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator Placement (PHASE2)
- Ketorolac Intravenous Regional Analgesia in Lower Limb Surgeries (NA)
- Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection (PHASE3)
- Treatment of Orthostatic Intolerance (PHASE1, PHASE2)
- Role of Multimodal Analgesia in Decreasing Perioperative Pain in Tibial Plateau Fractures (EARLY_PHASE1)
- Various Strategies to Reduce Acute Post Hemorrhoidectomy Pain: A Comparative Study (NA)
- A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents (PHASE3)
- Can PLIA Reduce Early Post-operative Pain After PAO Surgery? (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- INDOMETHACIN SODIUM CI brief — competitive landscape report
- INDOMETHACIN SODIUM updates RSS · CI watch RSS